
|Articles|September 11, 2015
Kim Statham Ringen on the Importance of Meeting Other Survivors
Author(s)Kim Statham Ringen
Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
Advertisement
Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
“I know all the statistics — the odds are against me,” Ringen says. “You don’t actually obtain hope until you meet another individual who’s pretty much just like you — same stage, same treatment options — and they’re out four years, five years, six years, seven years.”
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
3
Lynch Syndrome: Why Upper Endoscopies and Colonoscopy Prep Save My Life
4
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
5




